Similarly, a recent study showed that non-small cell lung cancer cell lines had different responsiveness against TTFields depending on BRCA1 pathway regardless of its doubling time10, suggesting that the cell doubling time as well as genetic background of cancer cells may be associated with tumour resistance to TTFields. The gene discussed is BRCA1; the disease is cancer.